129 results
·
36ms
·
Sources: EU EUDAMED, US FDA
Device, Hemostasis, Vascular
FDA Pre-Market Approval
FDA Class 3
·QUICKSEAL FEMORAL ARTERIAL CLOSURE SYSTEM
Device, Hemostasis, Vascular
FDA Pre-Market Approval
FDA Class 3
·QUICKSEAL CCS ARTERIAL CLOSURE SYSTEM
Device, Hemostasis, Vascular
FDA Pre-Market Approval
FDA Class 3
·QUICKSEAL ARTERIAL CLOSURE SYSTEM WITH Q-FOAM
Device, Hemostasis, Vascular
FDA Pre-Market Approval
FDA Class 3
·QUICKSEAL CONTROL FEMORAL ARTERIAL CLOSURE SYSTEM
Device, Hemostasis, Vascular
FDA Pre-Market Approval
FDA Class 3
·QUICKSEAL II ARTERIAL CLOSURE SYSTEM
Device, Hemostasis, Vascular
FDA Pre-Market Approval
FDA Class 3
·QUICKSEAL CONTROL ARTERIAL CLOSURE SYSTEM
Device, Hemostasis, Vascular
FDA Pre-Market Approval
FDA Class 3
·QUICKSEAL II ARTERIAL CLOSURE SYSTEM
Device, Hemostasis, Vascular
FDA Pre-Market Approval
FDA Class 3
·QUICKSEAL SURESHOT ARTERIAL CLOSURE SYSTEM
Device, Hemostasis, Vascular
FDA Pre-Market Approval
FDA Class 3
·QUICKSEAL CCS ARTERIAL CLOSURE SYSTEM
Device, Hemostasis, Vascular
FDA Pre-Market Approval
FDA Class 3
·QUICKSEAL SURESTAT ARTERIAL CLOSURE SYSTEM
Device, Hemostasis, Vascular
FDA Pre-Market Approval
FDA Class 3
·SURESTAT ARTERIAL CLOSURE SYSTEM
Device, Hemostasis, Vascular
FDA Pre-Market Approval
FDA Class 3
·QUICKSEAL CCS ARTERIAL CLOSURE SYSTEM
SpO2 Finger Adapter M-Flex
FDA UDI
MIPM Mammendorfer Institut für Physik und Medizin GmbH·04255629200362·
Mizzy Millennium
FDA UDI
Keystone Industries·H66860100491·Denture Acrylic QC Liquid
SpO2 Finger Adapter M-Flex
FDA UDI
MIPM Mammendorfer Institut für Physik und Medizin GmbH·EMIP50100491·
TEKNO®
FDA UDI
Tekno-Medical Optik-Chirurgie GmbH·04044684076032·EXTRACTING FORCEPS FIG. 49 ENGL. PATTE
SIMPLY SPECS
FDA UDI
FGX INTERNATIONAL INC.·00193033091333·
PULSECO HEMODYNAMIC MONITOR CM71
FDA 510(k)
FDA Class 2
·Cardiovascular
AUTOSOFT 30
FDA Adverse Event
Malfunction
·UNOMEDICAL DEVICES S.A. DE C.V.·Product code FPA·May 28, 2025
INSET 30
FDA Adverse Event
Malfunction
·UNOMEDICAL DEVICES S.A. DE C.V.·Product code FPA·August 13, 2025